Doctor Torunn I. Yock is a Professor at Harvard Medical School. She received her MD from Harvard Medical School and acquired a Masters in Community Health as a Fulbright Scholar from the University of New South Wales in Sydney, Australia. Her residency was at Massachusetts General Hospital. Her clinical practice is now comprised mostly of pediatric patients and survivors of childhood cancer. Dr. Yock’s research career has focused on measuring health outcomes to further improve upon cure rates and the quality of the survivorship in pediatric cancer patients and applying big data principals to research repositories. Her research has focused on the role of proton radiotherapy in pediatric cancer and both its power to mitigate late effects in our childhood cancer survivors, but also its potential pitfalls. Dr. Yock is the Primary Investigator of multiple pediatric protocols and she holds grant funding from a variety of sources including the NCI. She also participates in collaborative research with the Children’s Oncology Group, sitting on the Brain Tumor and Soft Tissue Sarcoma Committees, and is leading an NCI/MGH-sponsored multi-institutional registry enrolling pediatric patients treated with modern proton and photon radiotherapy and have accrued over 2600 patients. She has also authored over 120 articles and chapters and is an active member of ASTRO, ASCO, PROS, SIOP and serves on the American Board of Radiology to develop both the written and oral board examinations.